News About: Pharm. Industry
Listed pharmas had 19% decrease on average in stock price last year
Last year, stock prices of listed pharmaceutical companies rode a roller coaster, but ended the markets with a 19% decrease on average compared to the year before.
Even in the downturn, however, Yungjin Pharm surpris...
Amount of listed pharmas’ foreigner-owned shares appraised at KRW 3.2 trillion
The amount of listed pharmaceutical companies’ shares owned by foreign investors was appraised at the total 3.2 trillion.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of KOSPI and KOSDAQ listed ph...
Boryung Pharm signs KRW 83 billion export agreement with Ram Pharma
Boryung Pharm made an official announcement that it has signed an export contract of KRW 83 billion for Todula with Jordanian Ram Pharma. Todula is a calcium channel blocker(CCB) antihypertensive.
The agreement with ...
No. of advertisement deliberations exceeds 3 thousand cases a year
It was observed the number of medicine advertisement deliberation cases exceeded 3,000 cases in a year.
In accordance with the status on drug advertisement deliberation, announced by the Korea Pharmaceutical Manufact...
Chong Kun Dang and MSD Korea’s sales partnership for allergic rhinitis treatment
On the 26th, Chong Kun Dang(CEO Young-Joo Kim) announced a co-marketing agreement of ‘Nasonex,’ a allergic rhinitis treatment, with MSD Korea.
The agreement will allow Chong Kun Dang to exclusively sell and market N...
‘GSK’ ranks the top in No. of products suspended in supply
A pharmaceutical company which caused the highest number of incidents of suspending pharmaceutical supply to hospitals was a global pharmaceutical company, ‘GlaxoSmithKline(GSK).’
Since medical services on patients h...
Chong Kun Dang makes move to address shortage issue of Tamiflu
Chong Kun Dang(CEO Young-Joo Kim) announced to additionally supply the amount of Tamifly for 600 thousand people as the number of people infected by influenza reaches recently to the highest level.
Chong Kun Dang has...
Series of listed pharmas to decide on free issuance of new shares and cash & share dividends
Listed pharmaceutical companies have returned a part of their profits to shareholders through cash and stock dividends and free issue of new shares before settling their accounts at the end of the year.
Among the lis...
Hanmi’s Rosuzet achieves approx. KRW 20 billion sales only in a yearThe Hanmi Pharm’s(CEO Kwan-Sun Lee) hyperlipidemia therapy ‘Rosuzet’ achieved approximately KRW 20 billion sales(Jan 2016 to Nov 2016, based on UBIST) in a year after the launch...
|
Green Cross acquires WHO PQ for quadrivalent flu vaccineA tetravalent influenza(flu) vaccine certified by the international organization was developed in Korea for the second time in the world.
Green Cross(CEO Eun-Cheol Huh) announc...
|
